Literature DB >> 10630600

Dietary clay in the chemoprevention of aflatoxin-induced disease.

T D Phillips1.   

Abstract

Aflatoxins are harmful by-products of mold growth and, though invisible to the naked eye, are potentially fatal. The aflatoxin problem is long-standing and inextricable. Concerns about the aflatoxins originate from the strong implications of their involvement in disease and death in humans and animals, yet scientists and clinicians are still seeking ways to effectively deal with these dangerous and elusive chemicals. Safe, practical, and effective strategies for the detoxification of aflatoxin-contaminated food and feed are highly desirable. A simple and effective approach to the chemoprevention of aflatoxicosis has been to diminish or block exposure to aflatoxins via the inclusion of HSCAS clay in the diet. HSCAS clay acts as an aflatoxin enterosorbent that tightly and selectively binds these poisons in the gastrointestinal tract of animals, decreasing their bioavailability and associated toxicities. Further studies to delineate the molecular mechanisms of action have shown that the dicarbonyl system of aflatoxin is essential for tight binding by HSCAS. In these studies, adsorption data was fitted to multiple isotherm equations including the Langmuir, multi-Langmuir, general Freundlich, Langmuir-Freundlich, Toth and various transforms. Information derived included: the Gibbs standard free energy change of adsorption, enthalpy of adsorption, capacity, affinity, and heterogeneity coefficient. Computer modeling was also utilized to provide additional structural information and insight into the mechanism. Evidence suggests that aflatoxins may react at multiple sites on HSCAS particles, especially the interlayer region, but also at edges and basal surfaces. Since clay and zeolitic minerals comprise a broad family of functionally diverse chemicals, there may be significant hidden risks associated with their indiscriminate inclusion in the diet. All aflatoxin binding agents should be rigorously tested, paying particular attention to their effectiveness and safety in aflatoxin-sensitive animals and their potential for interactions with critical nutrients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630600     DOI: 10.1093/toxsci/52.suppl_1.118

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  43 in total

1.  Evaluation of the medicinal use of clay minerals as antibacterial agents.

Authors:  Lynda B Williams; Shelley E Haydel
Journal:  Int Geol Rev       Date:  2010-07-01       Impact factor: 3.958

2.  Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness.

Authors:  Charles C Horn; Marc Ciucci; Arun Chaudhury
Journal:  Auton Neurosci       Date:  2006-11-07       Impact factor: 3.145

3.  Reduction of individual or combined toxicity of fumonisin B1 and zearalenone via dietary inclusion of organo-modified nano-montmorillonite in rats.

Authors:  Aziza A El-Nekeety; Ahmed A El-Kady; Khaled G Abdel-Wahhab; Nabila S Hassan; Mosaad A Abdel-Wahhab
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-17       Impact factor: 4.223

Review 4.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

5.  Characterization and Safety of Uniform Particle Size NovaSil Clay as a Potential Aflatoxin Enterosorbent.

Authors:  A Marroquín-Cardona; Y Deng; J Garcia-Mazcorro; N M Johnson; N Mitchell; L Tang; A Robinson; J Taylor; J-S Wang; T D Phillips
Journal:  Appl Clay Sci       Date:  2011-12       Impact factor: 5.467

6.  Intervention trial with calcium montmorillonite clay in a south Texas population exposed to aflatoxin.

Authors:  Brad H Pollock; Sarah Elmore; Amelia Romoser; Lili Tang; Min-Su Kang; Kathy Xue; Marisa Rodriguez; Nicole A Dierschke; Holly G Hayes; H Andrew Hansen; Fernando Guerra; Jia-Sheng Wang; Timothy Phillips
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2016-07-28

7.  Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers.

Authors:  Carole Jubert; John Mata; Graham Bench; Roderick Dashwood; Cliff Pereira; William Tracewell; Kenneth Turteltaub; David Williams; George Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

8.  Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat.

Authors:  Charles C Horn; Bart C De Jonghe; Kathleen Matyas; Ralph Norgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-26       Impact factor: 3.619

9.  Modified hydra bioassay to evaluate the toxicity of multiple mycotoxins and predict the detoxification efficacy of a clay-based sorbent.

Authors:  K A Brown; T Mays; A Romoser; A Marroquin-Cardona; N J Mitchell; S E Elmore; T D Phillips
Journal:  J Appl Toxicol       Date:  2012-10-10       Impact factor: 3.446

10.  Comparative study on the aflatoxin B1 degradation ability of rumen fluid from Holstein steers and Korean native goats.

Authors:  Santi Devi Upadhaya; Ha Guyn Sung; Chan Hee Lee; Se Young Lee; Sun Woo Kim; Kyung Jin Cho; Jong K Ha
Journal:  J Vet Sci       Date:  2009-03       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.